Purpose: Invasive mucinous adenocarcinoma (IMA) is a unique subtype of lung
adenocarcinoma, characterized genomically by frequent KRAS mutations or specific gene …

Introduction Pulmonary invasive mucinous adenocarcinomas (IMAs) often present with
spatially separate lung lesions. Clonal relationship between such lesions, particularly those …

Invasive mucinous adenocarcinoma (IMA) is a unique histologic subtype of lung
adenocarcinoma. Recent studies document distinctive genetic alterations (eg, NRG1 …

Introduction: Invasive mucinous adenocarcinoma is a unique histologic subtype of lung
cancer, and our knowledge of its genetic and clinical characteristics is rapidly evolving …

Invasive mucinous adenocarcinoma is a variant of lung adenocarcinoma, which may be
mixed with nonmucinous adenocarcinoma. KRAS mutations are common, but other clinical …

Invasive mucinous adenocarcinoma (IMA) is a relatively rare subtype of lung
adenocarcinoma, composed of goblet and/or columnar tumour cells containing abundant …

Introduction Mucinous differentiation is observed in a subset of lung adenocarcinomas with
unique clinical and pathological features, but the biology of these neoplasms is poorly …

Invasive mucinous adenocarcinoma (IMA) of the lung is a unique variant of lung
adenocarcinoma. Aberrant mucin expression is associated with cancer development and …

Purpose: To identify druggable oncogenic fusions in invasive mucinous adenocarcinoma
(IMA) of the lung, a malignant type of lung adenocarcinoma in which KRAS mutations …

Background According to the latest the World Health Organization (WHO) classification in
2015, invasive mucinous adenocarcinoma (IMA) is defined as a new pathological subtype of …